Trimethylamine-N-Oxide, a Metabolite Associated with Atherosclerosis, Exhibits Complex Genetic and Dietary Regulation

Bennett, Brian J., Vallim, Thomas Q. de Aguiar, Wang, Zeneng, Shih, Diana M., Meng, Yonghong, Gregory, Jill, Allayee, Hooman, Lee, Richard +5 more·2013·Cell Metabolism
DOI 10.1016/j.cmet.2012.12.011

Cited by (1,000)

Items 901–1,000 of 1,000

  1. Gut Microbiota-Derived Leucine Promotes Cold-Induced Atherosclerosis by Inhibiting Macrophage Efferocytosis
    Yongtai Gong, Sen Rong Yan, Ning Fang, Yun Zhang, Ning Zhang, Long Li, Zhiqi Wang, Kunna Wang, Te Hou, Xuanrui Ji et al. · 2024 · Research Square
  2. Potential role of gut microbiota in cardiac arrhythmias
    Ramil Goel, Gurjit Singh, Carl J. Pepine · 2025 · American Heart Journal Plus Cardiology Research and Practice
  3. The role of trimethylamine-N-oxide in the development of cerebrovascular disease (brief review)
    Mansur Amirovich Kutlubaev, Airat R. Rakhmatullin, R. F. Kutlubaeva · 2023 · Neurology neuropsychiatry Psychosomatics
  4. Microbiome and atherosclerosis: state of the problem
    Ekaterina V. Verkhovskaya, Колесова Екатерина Павловна, Almaz G. Vanyurkin, Ekaterina Konstantinovna Zaikova, Olga Kalinina, Mikhail A. Chernyavskiy, А. L. Maslyanskiy, Aleksey N. Yakovlev, Alina Yu. Babenko, А. О. Конради et al. · 2025 · Arterial’naya Gipertenziya (Arterial Hypertension)
  5. The role of the gut microbiome in cardiovascular disease
    Mateusz Świątko, Paweł Sosnowski, Joanna Rybak, Marcin Grzebyk, Anna Tokarska, Aleksandra Arnista, Katarzyna Gawrońska, Agnieszka Waszczuk, Aleksandra Kołodziejczyk, Piotr Łapiński · 2025 · Journal of Education Health and Sport
  6. Shift in the urinary metabolome associated with 2,3,7,8-tetrachlorodibenzo-p-dioxin activation of the hepatic aryl hydrocarbon receptor
    Warren J. Sink, Russell R. Fling, Ali Yılmaz, Rance Nault, Delanie Goniwiecha, Jack R. Harkema, Stewart Francis Graham, Tim R. Zacharewski · 2025 · Scientific Reports
  7. Key roles of Drosophila flavin-containing monooxygenases in lipid metabolism and longevity
    Qi Wei, Yuan Xue, Jianfeng Fan, Jianya Su · 2025 · International Journal of Biological Macromolecules
  8. Ultrafine particulate matter exposure induces gut microbiota dysbiosis together with ER stress in the liver and worsened atherosclerosis
    Rajat Gupta, Candace Chang, David H. Gonzalez, P K Srivastava, Collin Le, Daniel P. Stefanko, Jocelyn A. Castellanos, Mohamad Navab, Srinivasa T. Reddy, Gregory A. Fishbein et al. · 2025 · Environment International
  9. Targeting FMO3 suppresses the malignant phenotype of colorectal cancer: evidence from bioinformatics to functional experiments
    Rong Su, Cuncun Huang, Zhe Jing, Shuping Qiu, Lihua Shao, Tinghong Jiao, Hongwei Wang, Hailong Li · 2026 · Future Science OA
  10. Prevention of colorectal cancer and modulation of murine gut microbiota using functional meats
    Patrick L. McAlpine, J. Borondo, Mar Grande, Lidia Gil-Martínez, Ana Falcón-Piñeiro, Alberto Baños, Estefanía Crespo Losada, Francisco Manuel Reyes‐Sosa, Miriam Caro Ruiz, Isabel Uribe Oyarbide et al. · 2026 · Food & Function
  11. 3,3′-diindolylmethane ameliorates non-alcoholic fatty liver disease by inhibiting the FMO3-TMAO axis in mice
    Runsheng Chen, Hua Liu, Tinfeng Yang, Zhonghao Jiang, Zeyu He, Xinpeng Zhang, Baolin Qian, Wenguang Fu · 2026 · Biochemical and Biophysical Research Communications
  12. Gut microbiota-derived metabolite trimethylamine N-oxide in major adverse cardiovascular events: Mechanisms, risk assessment, and therapeutic strategies
    Samuel Jaimez Alvarado, María Fernanda Flores Enciso, Amedeo Amedei, María Magdalena Aguirre‐García · 2026 · World Journal of Cardiology
  13. Nephropathy 1 Formula alleviates kidney injury by ameliorating mitochondrial dysfunction and pyroptosis in diabetic nephropathy through the TMAO-mROS-NLRP3 axis
    Tingting Wei, Yujiu Gao, Liting Zhu, Congcong Zeng, Rui Cai, Fu Rao, Yue Zhao, Xiaochun Zhang, Jiashun Yang, Yinrui Sheng et al. · 2026 · Chinese Journal of Natural Medicines
  14. The gut–brain axis and trimethylamine N-oxide: an emergent biomarker in neurological diseases
    Alessia Arangia, Rosanna Di Paola, Salvatore Cuzzocrea, Rosalba Siracusa, Ramona D’Amico, Daniela Impellizzeri · 2026 · Neuroscience
  15. Dietary Modulation of Gut Microbiome in High Cholesterol Diet–Induced Atherosclerosis
    Mani Sebastian, S. Abhirami, D. S. Amrutha, Rama P Haritha, Maya Gopinathan Pillai, A. Helen · 2026 · Advanced Gut & Microbiome Research
  16. Targeting the Gut–Heart Axis in Atherosclerosis: Microbial Metabolites, Molecular Mechanisms, and Precision Therapeutics
    Usha Adiga, Sampara Vasishta, Sachidananda Adiga, Adam A. Augustine · 2026 · Probiotics and Antimicrobial Proteins
  17. Trimethylamine N-Oxide Aggravates Thoracic Aortic Aneurysm by Inhibiting Axl to Promote Vascular Smooth Muscle Cell Dysfunction
    Shuai Leng, Zhiqiao Dang, Shishan Xue, Haijie Li, Baowei Shao, Yansong Ning, Leilei Zhang, Honglu Wang, Pengfei Zhang, Xilong Teng et al. · 2025 · Journal of Cardiovascular Pharmacology
  18. Sex Modifies Metabolic Pathways Associated with Lipids in Untargeted Metabolomics: The Coronary Artery Risk Development in Young Adults (CARDIA) Study, 2005–2006
    Autumn G. Hullings, Annie Green Howard, Katie A. Meyer, Christy L. Avery, Kari E. North, Sachin Mhatre, Wei Sha, Yuanyuan Li, Blake R. Rushing, Susan Sumner et al. · 2025 · Metabolites
  19. Gut Dysbiosis and Arrhythmogenesis: The Potential Role of Microbial Alterations and Small Intestinal Bacterial Overgrowth in Cardiac Arrhythmias
    Julia Soczyńska, Kamila Butyńska, Maja Ickiewicz, Oskar Soczyński, Kacper Pluta, Agnieszka Frątczak, Wiktor Gawełczyk, Sławomir Woźniak · 2026 · Gastroenterology Insights
  20. Gut Microbiota Biomarkers in Patients with Hepatocellular Carcinoma in the Era of Immune Checkpoint Inhibitors
    Maria Cerreto, Marta Maestri, Maria Pallozzi, Lucia Cerrito, Leonardo Stella, Gianluca Ianiro, Antonio Gasbarrini, Francesca Romana Ponziani · 2026 · Life
  21. Effects of Weight Loss Interventions on Gut Microbiota‐Derived Metabolites Linked to Cardiometabolic Health: A Systematic Review and Meta‐Analysis
    Fernando de Quadros Iorra, Leonardo André Swarowsky Loebens, Andrea Auler, Eduarda Caroline Tasso Nascimento, Beatriz D'Agord Schaan, Patrícia Martins Bock · 2026 · Obesity Reviews
  22. Choline, a nexus for neurocognitive nutrients: A narrative review
    N. Boldon, Barbara J. Strupp, Brian D. Cherrington, Jonathan F. Prather, Jill Fabricius Keith · 2026 · Nutrition Research
  23. The role of gut microbiome disruption in the development of metabolic dysfunction-associated kidney disease
    Michał Witkowski, Jarosław Przybyciński, Bartosz Wojciuk, Wiktor Czaja, Natalia Gołembiewska, Edyta Gołembiewska · 2026 · Acta Biochimica Polonica
  24. Atherosclerotic-dose TMAO accentuates redox imbalances and motor dysfunctions in a MPTP mouse model of Parkinson’s disease
    Paul-Ștefan Panaitescu, Ioana Bâldea, Vlad Alexandru Toma, Alexandra-Maria Nuţu, Claudia-Andreea Moldoveanu, Alexandra Sevastre-Berghian, Ana-Maria Vlase, Irina Camelia Haranguş, Carmen Anca Costache, Simona Valeria Clichici et al. · 2026 · Frontiers in Aging Neuroscience
  25. REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
    Marc‐Emmanuel Dumas, James K. Kinross, Jeremy Kirk Nicholson · 2014
  26. 14. Modulation of lipids, lipoproteins, and other biomarkers with egg consumption and exercise
    A.J. Kieffer, Rosemary L. Walzem · 2015 · Wageningen Academic Publishers eBooks
  27. Gut microbiota and lipid metabolism and metabolic syndrome
    Asim K. Duttaroy · 2021 · Elsevier eBooks
  28. Gut microbiota crosstalk mechanisms are key in pulmonary hypertension: The involvement of melatonin is instrumental too
    Steve Jacobs, Carmen Payne, S Shaboodien, T Kgatla, A Pretorius, Chrisstoffel Jumaar, Olakunle Sanni, GHAZWAN S. BUTROUS, Gerald J. Maarman · 2023 · Pulmonary Circulation
  29. Finding small molecular compounds to decrease trimethylamine oxide levels in atherosclerosis by virtual screening
    Jiaxin Luo, Aoqi Zhang, Yuan Yao, Jun Yuan · 2023 · Open Chemistry
  30. A Review on Epigenetic Toxicological Mechanisms of Sildenafil and Its Metabolites, the Emerging Pollutants
    Deng Chen, Xia Deng, Shiwei Jin · 2023 · Reviews of Environmental Contamination and Toxicology
  31. Oral Full Texts
    2023 · Turkish Journal of Biochemistry
  32. The gut microbe-derived metabolite trimethylamine N-oxide in patients with systemic lupus erythematosus
    Mohamed Salah, Rasha Samir Shemies, Mona Elhelaly Elsherbeny, Sarah Faisal, Asmaa Farouk Enein · 2024 · Scripta Medica
  33. NUTRITIONAL AND HEALTH BENEFITS OF DIETARY RESISTANT STARCH: A REVIEW
    Shilan Heshmati, Amir Saber, Hadi Abdollahzad · 2024 · Studies in Medical Sciences
  34. Innovative carnitine-fed rats model reveals resveratrol butyrate Ester's multimechanistic role in reducing TMAO and cardiovascular risk
    Chih‐Yao Hou, Cai-Sian Liu, Ming‐Kuei Shih, Asif Ali Bhat, You‐Lin Tain, Chang‐Wei Hsieh, Yu‐Wei Chen, Shin‐Yu Chen · 2025 · Journal of Functional Foods
  35. Non-alcoholic fatty liver disease and chronic kidney disease
    Светлана Владимировна Туркина, Тыщенко Ирина Андреевна, М. Н. Титаренко · 2024 · Экспериментальная и клиническая гастроэнтерология
  36. Altered Microbiota and Their Metabolism in Host Metabolic Diseases
    Beng San Yeoh, Matam Vijay–Kumar · 2018 · Springer eBooks
  37. Gut bacterial metabolite TMA induces hepatic metabolic stress and inflammation via mediation of A20
    Szczepan Kaluzny, Qiaozhu Su · 2021 · Proceedings of The Nutrition Society
  38. Gut Microbes in Cardiovascular Diseases
    Kewal Krishan Talwar, Mohit M. Bhagwati, Amitabh Yaduvanshi · 2022 · Springer eBooks
  39. TRIMETHYLAMINE OXIDE – FACTOR IN THE DEVELOPMENT OF ATHEROSCLEROSIS AND A POTENTIAL TARGET FOR DIETARY AND PHARMACOLOGICAL INTERVENTIONS
    Anna Olma, Witold Streb, Monika Lazar · 2023 · Polski Merkuriusz Lekarski
  40. Local metabolism in preclinical disease models studied with mass spectrometry imaging
    Jianhua Cao · 2022
  41. Ginger essential oil and citral ameliorate atherosclerosis via modulating TMAO and gut microbiota in ApoE−/− mice fed on Gubra amylin NASH diet with ʟ-carnitine
    Lee‐Yan Sheen, Suraphan Panyod, Wei‐Kai Wu, Sin-Yi Peng, Yea-Jing Tseng, Ya-Chi Hsieh, Rou-An Chen, Huai‐Syuan Huang, Yi‐Hsun Chen, Hsiao-Li Chuang et al. · 2022 · Research Square
  42. The Role of Gut Microbiota Dysbiosis Induced by Circadian Rhythm Disruption in Cardiometabolic Diseases
    Qin-yao Li, Chang Liu, Yi-xin Zhang, Jia‐Cen Sun, Weizhong Wang · 2024 · Preprints.org
  43. Identification of Fatty acid metabolism-Related Genes in the Progression from Non-Alcoholic Fatty Liver to Nonalcoholic fatty liver disease
    Xuancheng Xie, Tao Xiong, Yue Zhai, Xingli Liu, Wei Song, Meng Qiu Gao, Xiao He, Hongjie Fan, Gang Wang · 2024 · Research Square
  44. Carnitine and O-acylcarnitines in Pseudomonas aerguinosa: metabolism, transport, and regulation
    Jamie A. Meadows · 2015 · ScholarWorks -A service of University of Vermont Libraries (University of Vermont)
  45. The role of hepatic FoxO1 in insulin resistance
    Alisha V. Ling · 2015 · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
  46. Characterization of Flavin-containing Monooxygenase-3 (FMO3) as a Novel Genetic Determinant of Acetaminophen (APAP) Induced Hepatotoxicity
    Swetha Rudraiah · 2014 · OpenCommons at University of Connecticut (University of Connecticut)
  47. Intestinal Microbiota: An Emerging Target for Modifying Cardiovascular Health
    Shalin S Patel Mazyar Malakouti · 2014 · Journal of Diabetes & Metabolism
  48. Nonalcoholic Components of Wine and Atherosclerotic Cardiovascular Disease
    A O’Connor, GEORGES M. HALPERN, Rosemary L. Walzem · 2016 · Springer eBooks
  49. RESEARCH ARTICLE L-carnitine of red meat consumption contributes less in heart diseases progression as compared to low expressed PPARα leading to activation of mTOR1C
    Umar Bacha, Muhammad Ismail Nasir, Muhammad Asif Ali, Naveed Akbar, Aftab Ahmad Anjum, Javed, Tanveer Hussain, Abdul Wajid, Tayyab Shahzad, Rashid Anjum · 2013
  50. THE GENETIC ARCHITECTURE OF ATHEROSCLEROSIS AND THE ATHEROSCLEROSIS-ASSOCIATED METABOLITE TRIMETHYLAMINE-N-OXIDE IN THE DIVERSITY OUTBRED MOUSE POPULATION
    Tangi Smallwood · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  51. Metabolome response to glycemic load in a randomized, controlled, crossover feeding trial in humans
    Sally Barton · 2014 · ResearchWorks at the University of Washington (University of Washington)
  52. DIETARY TRIMETHYLAMINES, THE GUT MICROBIOTA,AND ATHEROSCLEROSIS
    Robert Koeth · 2013 · OhioLink ETD Center (Ohio Library and Information Network)
  53. The Regulation and Perturbation of Vascular Endothelial Permeability
    Susan M. Armstrong · 2014 · TSpace (University of Toronto)
  54. The Impact of Dietary Fat and Phosphatidylcholine on Increased Trimethylamine-N-oxide Levels
    Reem K.M. Ajlan · 2018 · VTechWorks (Virginia Tech)
  55. Effects of Egg Intake on Choline Metabolism and HDL Functionality in a Healthy Population
    Bruno S. Lemos · 2019 · OpenCommons at University of Connecticut (University of Connecticut)
  56. Post-prandial serum concentrations of Trimethylamine-N-oxide in overweight and obese adults with low and high systemic inflammation
    Stephanie Michelle Wilson · 2018 · Montana State University ScholarWorks (Montana State University)
  57. Role of Hepatic PEMT and Dietary Choline in the Development of Atherosclerosis
    Yumna Zia · 2017 · ERA: Education and Research Archive (University of Alberta)
  58. Função Mitodocondrial e Fatores de risco cardiovasculares em mulheres com obesidade submetidas a treinamento físico
    Camila Fernanda Costa e Cunha Moraes Brandão · 2019 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  59. Advanced Metabolomics for Metabolic Syndrome/Metabolic Diseases
    Xiaowei Sun, Jiangjiang Zhu · 2019 · Elsevier eBooks
  60. Novel Mediators of Diabetes-Associated Cardiovascular Disease
    Mary E. Gearing · 2017 · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
  61. Extended indirect calorimetry as a physiological phenotyping tool in mouse nutritional intervention studies, with a focus on metabolic programming by starches
    José M. S. Fernández‐Calleja · 2019
  62. MICROBIOTA INTESTINALE E RISCHIO CARDIOVASCOLARE
    Antonio Sircana, Elena Paschetta, Maurizio Cassader, Roberto Gambino, Giovanni Musso · 2020 · il Diabete
  63. Role of bile acid receptors in the regulation of cardiovascular diseases
    Yuji Shiozaki, Audrey L. Keenan, Makoto Miyazaki · 2020 · Elsevier eBooks
  64. Gut Microbiota and Risk for Atherosclerosis: Current Understanding of the Mechanisms
    Bidisha Dutta, Chitrine Biswas, Rakesh K. Arya, Shaik O. Rahaman · 2020 · Springer eBooks
  65. Nutrition as a Bridge between Communicable and Non-communicable Diseases: A Review
    Adediji Omolade Monisayo, Ethan Crystal Jane, Mougni Mohamed Azalati, Bei Han · 2020 · American journal of food science and technology
  66. Gut microbiota, lipid metabolism and systemic inflammation in common variable immunodeficiency: A translational research approach
    Magnhild Eide Macpherson · 2020 · NORA - Norwegian Open Research Archives
  67. Gut microbiota and metabolic diseases
    Carla Gras Guiteras · 2021 · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
  68. Gut microbiota and their effects on atherosclerosis, platelet function, and hypertension
    Asim K. Duttaroy · 2021 · Elsevier eBooks
  69. Avaliação da influência do vinho tinto sobre a microbiota intestinal e N-óxido de trimetilamina
    Elisa Alberton Haas · 2021
  70. Potential of phenolic compounds and their gut microbiota-derived metabolites to reduce microbial TMA formation: Application of an in vitro fermentation high throughput screening model
    Lisard Iglesias‐Carres, Emily S. Krueger, Jacob A. Herring, Jeffery S. Tessem, Andrew Peter Neilson · 2022
  71. Potential of phenolic compounds and their gut microbiota-derived metabolites to reduce microbial TMA formation: Application of an in vitro fermentation high throughput screening model
    Lisard Iglesias‐Carres, Emily S. Krueger, Jacob A. Herring, Jeffery S. Tessem, Andrew Peter Neilson · 2022 · ChemRxiv
  72. HUMAN GUT MICROBIOTA AND ITS EFFECTS ON HUMAN HEALTH IN NORMAL AND PATHOLOGICAL CONDITIONS
    Anca Magdalena Munteanu, Raluca Cursaru, Loreta Guja, Simona Carniciu, Alina Maria Borcan, Dana Popescu‐Spineni · 2017 · Romanian Medical Journal
  73. Potential of phenolic compounds and their gut microbiota-derived metabolites to reduce microbial TMA formation: Application of an in vitro fermentation high throughput screening model
    Lisard Iglesias‐Carres, Emily S. Krueger, Jacob A. Herring, Jeffery S. Tessem, Andrew Peter Neilson · 2021 · ChemRxiv
  74. Emerging Applications of Metabolomics in Drug Development
    Junli Ma, Ningning Zheng, Guo-Xiang Xie, Hou-Kai Li · 2018 · Journal of Metabolomics & Systems Biology
  75. Trimethylamine N-Oxide (TMAO) as a Biomarker
    Rosita Gabbianelli, Laura Bordoni · 2022 · Biomarkers in disease
  76. Gut Microbial Metabolite Trimethylamine-N-Oxide and Its Role in Cardiovascular Diseases
    Shubham Barik, Aritra Mukherjee, Angelina Job Kolady, Boda Karunakar, Tony Grace · 2022 · IntechOpen eBooks
  77. Restoring Eubiosis in Intestinal Microbiota as a Therapeutic Strategy for Chronic Kidney Disease
    Álvaro Zamudio Tiburcio · 2022 · Gastroenterology  Medicine & Research
  78. Trimethylamine N-Oxide (TMAO) as a Biomarker
    Rosita Gabbianelli, Laura Bordoni · 2022 · Biomarkers in disease
  79. Kardiyovasküler hastalıklarda bağırsak mikrobiyotasının rolü
    Ebrar Kökcü, Üla Akil, Esma Asil · 2022 · Toros University Journal of Food Nutrition and Gastronomy
  80. Identification of oral bacteria in the gut, atherosclerotic plaque, and cultured blood samples of patients with cardiovascular diseases – A secondary analysis of metagenomic microbiome data
    Thilini N. Jayasinghe, Aditi Chopra, Ricardo Franco‐Duarte, Anjale Rajagopal, Phannaphat Choowong, Pedro O. Soares, Teresa Rito, Joerg Eberhard · 2023 · Research Square
  81. Identification of oral bacteria in the gut, atherosclerotic plaque, and cultured blood samples of patients with cardiovascular diseases – A secondary analysis of metagenomic microbiome data
    Thilini N. Jayasinghe, Aditi Chopra, Ricardo Franco‐Duarte, Anjale Rajagopal, Phannaphat Choowong, Pedro O. Soares, Teresa Rito, Joerg Eberhard · 2023 · Research Square
  82. Vitamin B2 Riboflavin
    2018 · Royal Society of Chemistry eBooks
  83. Machine learning-based identification of key lipid metabolism-related genes and associated ceRNA networks in NAFLD
    Xirui Fan, Rong Qin, Yankun Zhu, Weikang Huang, Yu Su, Yulu Zhang, Likun Wang, Hui Wang · 2023 · Research Square
  84. A novel chaperone flavin-containing monooxygenase 2 confers cardioprotection against ischemia through its disulfide-bond catalytic activity
    Qingnian Liu, Jiniu Huang, Hao Ding, Yue Tao, Changchen Xiao, Yingchao Wang, Rongrong Wu, Cheng Ni, Zhiwei Zhong, Wei Ming Zhu et al. · 2023 · Research Square
  85. Dynamic Effects of Ketogenic Diet on Autophagy and Cell Cycle in a Mouse Model of CT26+ Colon Cancer
    Junrong Yang, Ning Zhang, Muhammad Akram Khan, Qingpeng Wang, Zhengping Wang, Quiqin Liu, Lanjie Li, Jun Han, Abdul Asim Farooq, Aayesha Riaz et al. · 2023 · Pakistan Journal of Zoology
  86. Regulation of Trimethylamine N-oxide in Treatment of Cardiometabolic Diseases. Doctoral Thesis
    Melita Ozola · 2023
  87. THE ROLE OF THE INTESTINAL MICROBIOTA METABOLITE TMAO IN THE PATHOGENESIS OF VARIOUS DISEASES
    Nadezhda Samoilova-Bedych, Е.М. Laryushina, Alexandr Marchenko, А.К. Сейсенбекова · 2024 · Farmaciâ Kazahstana
  88. Exploring the Multi-Omics Causal Effect with Abdominal Aortic Aneurysm: A Bidirectional and After-Meta Mendelian Randomization Analysis
    Fei Teng, Youyin Tang, Zhangyu Lu, Zheyu Chen · 2024 · SSRN Electronic Journal
  89. Additional file 11 of FMO3 deficiency of duck leads to decreased lipid deposition and increased antibacterial activity
    Xingzheng Li, Jianlou Song, Xuefeng Shi, Mingyi Huang, Lei Liu, Guoqiang Yi, Ning Yang, Guiyun Xu, Jiangxia Zheng · 2022 · Figshare
  90. Additional file 9 of FMO3 deficiency of duck leads to decreased lipid deposition and increased antibacterial activity
    Xingzheng Li, Jianlou Song, Xuefeng Shi, Mingyi Huang, Lei Liu, Guoqiang Yi, Ning Yang, Guiyun Xu, Jiangxia Zheng · 2022 · Figshare
  91. Additional file 12 of FMO3 deficiency of duck leads to decreased lipid deposition and increased antibacterial activity
    Xingzheng Li, Jianlou Song, Xuefeng Shi, Mingyi Huang, Lei Liu, Guoqiang Yi, Ning Yang, Guiyun Xu, Jiangxia Zheng · 2022 · Figshare
  92. Additional file 8 of FMO3 deficiency of duck leads to decreased lipid deposition and increased antibacterial activity
    Xingzheng Li, Jianlou Song, Xuefeng Shi, Mingyi Huang, Lei Liu, Guoqiang Yi, Ning Yang, Guiyun Xu, Jiangxia Zheng · 2022 · Figshare
  93. Additional file 10 of FMO3 deficiency of duck leads to decreased lipid deposition and increased antibacterial activity
    Xingzheng Li, Jianlou Song, Xuefeng Shi, Mingyi Huang, Lei Liu, Guoqiang Yi, Ning Yang, Guiyun Xu, Jiangxia Zheng · 2022 · Figshare
  94. Distribution characteristics and diagnostic value of TMAO and its precursors in HFpEF and HFrEF
    Qing Li, Yulong Song, Xianliang Wang, Jingyuan Mao, Zhiqiang Zhao · 2024 · Research Square
  95. Effect of heat stress and feed type on trimethylamine concentration and fishy odor of duck eggs
    Pachara Pearodwong, Winai Kaewlamun, Sarawanee Khunmanee, Thuwanon Boonkerd, Thananon Junsuri, Kajohn Nitiwararak, Pantira Hempattarasuwan, Pattrarat Chanchaithong · 2024 · The Thai Journal of Veterinary Medicine
  96. The Role of the Intestinal Microbiota in NAFLD Onset and Progression
    Iris Pinheiro · 2024 · IntechOpen eBooks
  97. Gut Microbiome Modulation of Innate Immunity in Neurodegenerative Diseases
    Andrea R. Merchak, Kelly B. Menees, MacKenzie L. Bolen, Malú G. Tansey · 2024 · Oxford University Press eBooks
  98. Serum Trimethylamine N-Oxide Levels as a Predictor of Peripheral Arterial Disease in Kidney Transplant Recipients
    Hsiao-Hui Yang, Yen-Cheng Chen, Chin‐Hung Liu, Bang‐Gee Hsu · 2024 · Medical Science Monitor
  99. Lipid metabolism correction with statins and probiotics
    Natalia V. Baryshnikova, L'niavina Vm, Yury P. Uspenskiy, Alexander N. Suvorov, Е. И. Ермоленко · 2025 · Экспериментальная и клиническая гастроэнтерология
  100. Colonization with Oxalobacter formigenes slows the progression of CKD and reduces cardiac remodeling in CKD
    Xiaozhong Xiong, Melody L. Ho, Karim Jaber, Rashmi Mishra, Amalya M. Charytan, Nadim Zaidan, Florencia Schlamp, Glenn I. Fishman, Lama Nazzal · 2025 · bioRxiv (Cold Spring Harbor Laboratory)